TRAW Insider Trading Activity and SEC Form 4 Filings
TRAW insider trading summary
Over the past 12 months, insiders at Traws Pharma, Inc. (TRAW) reported 2 open-market purchases worth $2.0M by 2 insiders and no sales on SEC Form 4. Net insider buying was $2.0M.
Latest TRAW insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 16, 2026 | Orbimed Advisors LLC | 10% Owner | Buy | $998K (597,729 @ $1.67) |
| Apr 16, 2026 | OrbiMed Capital GP VIII LLC | 10% Owner | Buy | $998K (597,729 @ $1.67) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.